Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Pubblicazioni
Progetti
Persone
Terza Missione
Competenze
Settori
Strutture
IT
EN
☰
UNI-FIND
|
UNI-FIND
unito.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Pubblicazioni
Progetti
Persone
Terza Missione
Competenze
Settori
Strutture
☰
Pubblicazioni
BLOOD CANCER JOURNAL
Rivista
Codice:
E205920
ISSN:
2044-5385
Dati Generali
Dati Generali
Pubblicazioni (20)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups.
Articolo
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells
Articolo
Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies
Articolo
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study
Articolo
CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies
Articolo
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
Articolo
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study
Articolo
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib
Articolo
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
Articolo
Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma
Articolo
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial
Articolo
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials
Articolo
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life
Articolo
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial
Articolo
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
Articolo
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score
Articolo
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients
Articolo
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Articolo
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab
Articolo
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia.
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
